Ketamine Treatment for Chronic Pain in Spring, TX
For carefully selected adults with persistent neuropathic pain or complex regional pain syndrome, medically supervised IV ketamine may be considered when standard treatments have not provided adequate relief.
Vitality Medical Clinic serves Spring, The Woodlands, Conroe, Shenandoah, Oak Ridge North, Magnolia, and North Houston.
A Physician-Led, Evidence-Based Approach to Chronic Pain
Chronic pain is pain that persists or recurs for more than three months. It can disrupt sleep, movement, mood, work, and relationships. Effective care starts by identifying the pain mechanism—not simply assigning a pain score—and setting practical goals for comfort and function.
At Vitality Medical Clinic, ketamine is not presented as a cure or a first-line treatment. We evaluate the diagnosis, previous treatments, medical and psychiatric history, current medications, and individual risks before discussing whether an IV ketamine infusion may fit a broader pain-management plan.
Which Chronic Pain Conditions May Be Considered?
Research is not equally strong for every pain diagnosis. A consultation helps determine whether symptoms have a neuropathic or centralized component and whether established therapies have been adequately tried.
Complex Regional Pain Syndrome
CRPS is characterized by disproportionate regional pain and may include sensitivity, swelling, temperature or color changes, and impaired movement. Consensus guidance finds moderate evidence for benefit from certain IV ketamine protocols, although results vary.1,4
Neuropathic Pain
Burning, electric, shooting, or touch-sensitive pain may reflect nerve injury or dysfunction. A systematic review found pain reduction after ketamine in some neuropathic pain studies, but adverse effects were more frequent and protocols varied.3
Other Refractory Pain Syndromes
Some patients with fibromyalgia, spinal cord injury pain, post-surgical pain, or mixed chronic pain ask about ketamine. Evidence is limited or inconsistent, so consideration must be individualized and should not replace diagnosis-specific care.1,2
Ketamine is not appropriate for every type of back pain, arthritis, headache, or generalized pain. Listing a condition does not mean treatment will be recommended.
How Ketamine May Affect Pain Signaling
Ketamine primarily blocks N-methyl-D-aspartate (NMDA) receptors involved in glutamate signaling. NMDA activity contributes to central sensitization—a state in which the nervous system becomes unusually responsive and continues amplifying pain signals. By modifying this pathway, ketamine may temporarily reduce pain hypersensitivity in some patients. Its actions are complex and extend beyond a single receptor.
Response is not guaranteed. The clinically meaningful question is whether treatment improves function—such as sleep, walking, daily activity, or participation in rehabilitation—not only whether a number on a pain scale changes.
What the Research Shows
| Evidence area | What is known | Key limitation |
|---|---|---|
| Chronic non-cancer pain overall | Systematic reviews suggest short-term pain reduction in some patients. | Long-term effectiveness is unclear, and study protocols differ substantially.2 |
| Complex regional pain syndrome | Professional consensus guidelines identify moderate evidence for improvement lasting up to approximately 12 weeks with studied multi-day protocols. | Evidence is based on limited studies; results do not establish one universal regimen.1 |
| Neuropathic pain | A meta-analysis of randomized trials found pain reduction during and after treatment. | Adverse effects occurred more often, and certainty about sustained benefit remains limited.3 |
| Function and quality of life | Some studies report improvement. | Results are mixed, and pain reduction does not always translate into functional gain.2 |
What to Expect From a Ketamine Evaluation and Infusion
Clinical evaluation
We review the pain diagnosis, duration, previous therapies, medical conditions, psychiatric history, substance-use risk, and current medications.
Personalized plan
If appropriate, the clinician discusses expected benefits, alternatives, off-label use, possible adverse effects, treatment goals, and stopping criteria.
Monitored infusion
Ketamine is administered in a clinical setting. Blood pressure, pulse, oxygenation, symptoms, and clinical response are monitored according to the individualized protocol.
Recovery and follow-up
Observation continues after treatment. Patients need a responsible adult to drive them home and must avoid driving, alcohol, and important decisions for the period directed by the clinician.
Safety, Side Effects, and Who May Not Be a Candidate
Temporary effects can include dissociation or a dream-like feeling, dizziness, nausea, blurred vision, anxiety, sedation, and increases in blood pressure or heart rate. Less common but important risks include significant cardiovascular or psychiatric reactions. Repeated or high cumulative exposure has also raised concerns about urinary tract injury and liver or biliary problems.1,2,5
Ketamine may be inappropriate—or may require specialist clearance—in people with uncontrolled hypertension, unstable cardiovascular disease, active psychosis, certain substance-use concerns, pregnancy, significant liver disease, elevated intracranial or intraocular pressure in relevant clinical settings, or other individualized risks. Medication interactions and the use of opioids, benzodiazepines, alcohol, stimulants, and sedatives must be reviewed.
Professional consensus recommendations emphasize careful patient selection, trained personnel, appropriate monitoring, and readiness to manage cardiovascular or airway complications.1
Frequently Asked Questions
Is ketamine FDA-approved for chronic pain?
No. Ketamine is FDA-approved for induction and maintenance of general anesthesia. Use for chronic pain is off-label, meaning a licensed clinician may consider it based on medical judgment, available evidence, and informed consent.5
How long can pain relief last?
Duration varies. Some studies report short-term benefit lasting from days to weeks, and selected CRPS studies have reported benefit for up to about 12 weeks. Other patients have little or no meaningful response. Long-term effectiveness remains uncertain.1,2
How many ketamine infusions are needed for chronic pain?
There is no single evidence-based schedule appropriate for every diagnosis or patient. Published studies use different doses, infusion durations, and treatment series. A plan should be diagnosis-specific and adjusted only after assessing response and tolerability.
Will ketamine replace my current pain treatment?
Usually not. Ketamine is best considered as one possible component of multimodal care, which may include physical rehabilitation, condition-specific medication, behavioral pain strategies, sleep treatment, and coordination with pain, neurology, rheumatology, orthopedic, or surgical specialists.
Does ketamine reduce the need for opioids?
That cannot be promised. Evidence that chronic-pain ketamine reliably reduces long-term opioid use is insufficient. Do not change opioid or other medication doses without the prescribing clinician.
Can I drive home after an infusion?
No. You will need a responsible adult to drive you home. Follow all individualized post-treatment restrictions provided by the clinic.
Does insurance cover IV ketamine for chronic pain?
Coverage varies and is often limited because chronic-pain use is off-label. Contact the clinic and your health plan for current benefit and payment information.
Where is Vitality Medical Clinic located?
Vitality Medical Clinic is at 2219 Sawdust Road, Suite 302, Spring, TX 77380, convenient to The Woodlands, Shenandoah, Oak Ridge North, Conroe, Magnolia, and North Houston.
Request a Chronic Pain and Ketamine Consultation
Find out whether medically supervised IV ketamine is a reasonable option for your diagnosis, treatment history, and goals.
Medical References
- Cohen SP, Bhatia A, Buvanendran A, et al. Consensus Guidelines on the Use of Intravenous Ketamine Infusions for Chronic Pain. Regional Anesthesia and Pain Medicine. 2018;43(5):521-546. PubMed.
- Tran K, Kamel C, Young C. Ketamine for Chronic Non-Cancer Pain: A 2023 Update. Canadian Agency for Drugs and Technologies in Health; 2023. NCBI Bookshelf.
- Guimarães Pereira JE, et al. Efficacy and Safety of Ketamine in the Treatment of Neuropathic Pain: A Systematic Review and Meta-Analysis of Randomized Controlled Trials. Journal of Pain Research. 2022;15:1011-1037. PubMed.
- Chitneni A, et al. Use of Ketamine Infusions for Treatment of Complex Regional Pain Syndrome: A Systematic Review. Cureus. 2021;13(10):e18910. PubMed.
- U.S. Food and Drug Administration. Understanding Current Use of Ketamine for Emerging Areas of Therapeutic Interest. June 27, 2024. FDA.
This page provides general education and does not establish a clinician-patient relationship or replace individualized medical advice. Evidence and eligibility vary by diagnosis. Seek emergency care for new weakness, loss of bowel or bladder control, chest pain, severe shortness of breath, suicidal thoughts, or other urgent symptoms.